mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-07 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-07 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |